FIG. 5.
A: Contraction-stimulated 2DG uptake in soleus and EDL without or with 200 μmol/L NSC23766, 1-h preincubation (n = 12). B: Contraction-stimulated 2DG uptake in soleus and EDL without or with 10 μmol/L Rac1 Inhibitor II (Inhib II), 1-h preincubation (n = 10). C: Representative blots and bar graphs show contraction-stimulated p-AMPKThr172 and p-ACCSer212 in soleus and EDL muscle without or with 200 μmol/L NSC23766. D: Representative blots and bar graphs show contraction-stimulated p-AMPKThr172, p-ACCSer212, and p-PAKThr423 signaling and Rac1 and GLUT4 total protein in soleus and EDL muscle without or with 10 μmol/L Rac1 Inhibitor II (Inhib II). E: Insulin-stimulated (60 nmol/L) 2DG uptake in mouse white adipose (gonadal) tissue without or with 10 μmol/L Rac1 Inhibitor II (Inhib II), 1-h preincubation (n = 8). Statistical significance between basal and contraction is indicated by *P < 0.05; **P < 0.01; ***P < 0.001. Effect of inhibitor on contraction-stimulated 2DG or p-PAKThr423 is indicated by #P < 0.05; ##P < 0.01; ###P < 0.001. Main effect of inhibitor is indicated by †P < 0.05. Values represent mean ± SEM.